Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 21 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

6 trials in Phase 3/4

Results Transparency

18%

2 of 11 completed trials have results

Key Signals

5 recruiting2 with results

Enrollment Performance

Analytics

Phase 1

7(38.9%)

Phase 3

3(16.7%)

Phase 4

3(16.7%)

N/A

3(16.7%)

Phase 2

2(11.1%)

18Total

Phase 1(7)

Phase 3(3)

Phase 4(3)

N/A(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials

NCT07738952Phase 1Not Yet Recruiting

Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder

Role: lead

NCT05608148Phase 1Recruiting

Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors

Role: lead

NCT05438459Phase 1Recruiting

GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites

Role: lead

NCT06983210Phase 2Recruiting

Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma

Role: collaborator

NCT05863234Phase 1Recruiting

Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia

Role: collaborator

NCT03620474Phase 1Completed

Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis

Role: collaborator

NCT02410850Recruiting

Long Term Oral Appliance Therapy Effectiveness for Obstructive Sleep Apnea Syndrome

Role: collaborator

NCT05680623Completed

Clinical and Economic Validation of the ISGPS Definition of PPAP

Role: collaborator

NCT04730037Phase 3Completed

Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI)

Role: lead

NCT02276937Phase 2Unknown

Randomized Phase IIb Trial of DVC1-0101

Role: lead

NCT04621136Phase 1Completed

PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity

Role: lead

NCT04686006Completed

Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side Effects

Role: lead

NCT03144635Phase 4Completed

A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir

Role: lead

NCT00333164Phase 3Completed

Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis

Role: collaborator

NCT02462304Phase 4Unknown

To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema

Role: collaborator

NCT01699698Not ApplicableCompleted

Pancreatic Juice Diagnosis From Duodenum

Role: collaborator

NCT02158624Not ApplicableUnknown

Ranibizumab Treatment for Age-Related Macular Degeneretion

Role: lead

NCT01514019Phase 4Completed

An Open-label, Single-dose, Two-treatment, Randomized, Cross-over Study to Investigate the Effects of the SLCO2B1 c.1457C>T Polymorphism and Apple Juice on the Pharmacokinetics and Pharmacodynamics of Acebutolol in Healthy Korean and Japanese Volunteers

Role: collaborator

NCT00676949Phase 1Completed

Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors

Role: lead

NCT00670787Phase 3Completed

Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial

Role: lead